Saroj Namrata, Chief Business Officer at Ocular Therapeutix, Inc. ($OCUL), made one open market sale of company shares in the last year, totaling nearly $278,000. Her most recent sale occurred on November 5, 2025. She ranks 7,723rd among 11,678 individual insiders for sales volume, well below the average of $8.6 million across about 6.4 transactions per insider. Namrata recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Saroj Namrata | Chief Business Officer | A | Common Stock | 79112 | $0.00 | 254,620.0000 | 187,241,483 | 45.08% | 0.04% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Saroj Namrata | Chief Business Officer | A | Stock Option (Right to Buy) | 240932 | $0.00 | 240,932.0000 | 187,241,483 | 9999.99% | 0.13% |
| Nov. 5, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Saroj Namrata | Chief Business Officer | S | Common Stock | 25865 | $10.74 | 174,135.0000 | 183,919,808 | 12.93% | 0.01% |